A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...

Senators challenged Kennedy, who was nominated as health secretary by President Trump, on his long track record of ...

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...

States and providers regained access to a key healthcare payments portal late Tuesday amid pushback over the Trump ...

The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...

BioAge scrapped the drug at the center of its $198 million initial public offering last year. Elsewhere, Akero and 89bio raised $600 million combined and Allakos laid off staff.